Peregrine Pharmaceuticals Announces European Patent Grant For Vascular Targeting Agents

Avanir And Peregrine Execute Commercial License Agreement For Anti-Cancer Antibody

Avid Bioservices To Expand Manufacturing Capacity

Avid Bioservices Signs Manufacturing Supply Agreement For Production Of Recombinant Protein

Peregrine Appoints New Transfer Agent

Avid Bioservices Signs Product Development Agreement With Medipharm Biotech For Tumor Necrosis Therapy

Peregrine Provides Clarification on NASDAQ Trading Halt

Peregrine's Transfer Agent and DTC Reconcile Shares Held in Trust by DTC

Peregrine Researchers Receive $1.68 Million NIAID Biodefense Grant For Research Into The Treatment Of Lassa Fever

Avid Bioservices Signs Manufacturing Supply Agreement For Production Of Monoclonal Antibodies